Reverse 5' caps in RNAs made in vitro by phage RNA polymerases - PubMed (original) (raw)
Reverse 5' caps in RNAs made in vitro by phage RNA polymerases
A E Pasquinelli et al. RNA. 1995 Nov.
Abstract
We show that about one-third of the RNAs produced in vitro by viral RNA polymerases in the presence of m7GpppG dinucleotides have unusual 5' caps. In these RNAs, the initiating dinucleotide is incorporated in an orientation opposite to that expected so that the 7-methyl guanine (m7G) nucleotide is adjacent to the body of the RNA, making a "reverse" cap. The doubly methylated dinucleotide, m7GpppGm, containing a 2' O-methylated guanine (Gm) is incorporated only in the reverse orientation. Precursors of U1 snRNAs containing reverse caps are recognized by antibodies specific for the m7G cap structure. When injected into Xenopus laevis oocyte nuclei, reverse-capped pre-U1 RNAs are exported considerably more slowly than normal. Furthermore, U1 RNAs with reverse caps exhibit a striking defect in nuclear import that can be attributed to the failure of reverse caps to be hypermethylated to m2,2,7G caps. Thus, the presence of reverse-capped RNAs in RNA preparations may affect conclusions about the efficiency and extent of certain m7G cap-dependent processes.
Similar articles
- Multiple cis-acting signals for export of pre-U1 snRNA from the nucleus.
Terns MP, Dahlberg JE, Lund E. Terns MP, et al. Genes Dev. 1993 Oct;7(10):1898-908. doi: 10.1101/gad.7.10.1898. Genes Dev. 1993. PMID: 8405997 - Retention and 5' cap trimethylation of U3 snRNA in the nucleus.
Terns MP, Dahlberg JE. Terns MP, et al. Science. 1994 May 13;264(5161):959-61. doi: 10.1126/science.8178154. Science. 1994. PMID: 8178154 - Oocyte expression with injection of purified T7 RNA polymerase.
Altafaj X, Joux N, Ronjat M, De Waard M. Altafaj X, et al. Methods Mol Biol. 2006;322:55-67. doi: 10.1007/978-1-59745-000-3_5. Methods Mol Biol. 2006. PMID: 16739716 Review. - Unconventional rules of small nuclear RNA transcription and cap modification in trypanosomatids.
Tschudi C, Ullut E. Tschudi C, et al. Gene Expr. 2002;10(1-2):3-16. Gene Expr. 2002. PMID: 11868986 Free PMC article. Review.
Cited by
- mRNA vaccines: A novel weapon to control infectious diseases.
Tian Y, Deng Z, Yang P. Tian Y, et al. Front Microbiol. 2022 Oct 4;13:1008684. doi: 10.3389/fmicb.2022.1008684. eCollection 2022. Front Microbiol. 2022. PMID: 36267192 Free PMC article. Review. - The matrix protein of vesicular stomatitis virus inhibits nucleocytoplasmic transport when it is in the nucleus and associated with nuclear pore complexes.
Petersen JM, Her LS, Varvel V, Lund E, Dahlberg JE. Petersen JM, et al. Mol Cell Biol. 2000 Nov;20(22):8590-601. doi: 10.1128/MCB.20.22.8590-8601.2000. Mol Cell Biol. 2000. PMID: 11046154 Free PMC article. - Synthesis and properties of mRNAs containing the novel "anti-reverse" cap analogs 7-methyl(3'-O-methyl)GpppG and 7-methyl (3'-deoxy)GpppG.
Stepinski J, Waddell C, Stolarski R, Darzynkiewicz E, Rhoads RE. Stepinski J, et al. RNA. 2001 Oct;7(10):1486-95. RNA. 2001. PMID: 11680853 Free PMC article. - Novel "anti-reverse" cap analogs with superior translational properties.
Jemielity J, Fowler T, Zuberek J, Stepinski J, Lewdorowicz M, Niedzwiecka A, Stolarski R, Darzynkiewicz E, Rhoads RE. Jemielity J, et al. RNA. 2003 Sep;9(9):1108-22. doi: 10.1261/rna.5430403. RNA. 2003. PMID: 12923259 Free PMC article. - Development of an optimized RNA-based murine norovirus reverse genetics system.
Yunus MA, Chung LM, Chaudhry Y, Bailey D, Goodfellow I. Yunus MA, et al. J Virol Methods. 2010 Oct;169(1):112-8. doi: 10.1016/j.jviromet.2010.07.006. Epub 2010 Jul 14. J Virol Methods. 2010. PMID: 20637238 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous